To submit a help request for a project, click the button below. Before filling out the form, you will be asked to agree to submission terms, then log in with your NIH credentials if you have not done so already. Questions and general inquiries can be emailed to ccbr@mail.nih.gov.
Ask For Help
Upcoming Classes
Recent CCBR Publications
- 10/01/2020 - Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
- 10/01/2020 - Host gene expression modulated by Zika virus infection of human-293 cells
- 10/01/2020 - A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau
- 09/01/2020 - Whole-Exome Profiling of NSCLC Among African Americans
- 09/01/2020 - The genomic landscape of Mongolian hepatocellular carcinoma
- 08/01/2020 - Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth
- 08/01/2020 - Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI
- 07/01/2020 - Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro
- 06/01/2020 - Drugs targeting tumor-initiating cells prolong survival in a post-surgery, post-chemotherapy ovarian cancer relapse model
- 06/01/2020 - Induction of DNMT3B by PGE2 and IL6 at distant metastatic sites promotes epigenetic modification and breast cancer colonization
- 05/01/2020 - Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquinated proteins and RA190 cytoxicity
- 03/01/2020 - An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
- 02/01/2020 - Mosaicism for KCNJ5 causing early-onset primary Aldosteronism due to bilateral Adrenacortical Hyperplasia
- 01/01/2020 - Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
- 01/01/2020 - The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation
- 01/01/2020 - Evaluation of the anti-tumor activity of the humanized monoclonal antibody NEO-201 in preclinical models of ovarian cancer